The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer

BACKGROUND: The hypoxia marker pimonidazole is a candidate biomarker of cancer aggressiveness. We investigated the transcriptional programme associated with pimonidazole staining in prostate cancer. METHODS: Index tumour biopsies were taken by image guidance from an investigation cohort of 52 patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Ragnum, H B, Vlatkovic, L, Lie, A K, Axcrona, K, Julin, C H, Frikstad, K M, Hole, K H, Seierstad, T, Lyng, H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453458/
https://www.ncbi.nlm.nih.gov/pubmed/25461803
http://dx.doi.org/10.1038/bjc.2014.604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453458/
https://www.ncbi.nlm.nih.gov/pubmed/25461803
http://dx.doi.org/10.1038/bjc.2014.604

Ejemplares similares